April 23, 2014
  • New Mexico Pharmacists First Approved to Prescribe Overdose Drug

    New Mexico pharmacists, who already have some prescriptive authority, can now also prescribe the antioverdose drug naloxene—the first pharmacists to be able to do so in the United States. The required training program has been so popular among pharmacists that the state association has had to add additional sessions. Here are the details.

  • How Effective Are Neuraminidase Inhibitors in Influenza?

    Worldwide, nations have stockpiled Tamiflu and similar products in fear of an influenza pandemic. A new survey out of Britain suggests those actions may have been premature, however. Find out about an analysis of research that suggests neuraminidase inhibitors are not as effective as previously believed and also may produce more side effects than expected.

  • New Therapy Produces High HCV Cure Rates for Patients With Cirrhosis

    Cirrhosis patients with hepatitis C have to use interferon-based agents that cause multiple side effects and fail to prevent relapses. In a recent study, however, a well-tolerated combination therapy posted cure rates of more than 90%. What is the combination and when is it likely to be available for patients?

  • Pharmacists Help Stroke Patients Reduce CV
    Disease Risks

    Stroke patients in a group with a pharmacist case manager improved cardiovascular risk factors considerably more than a similar group with a nurse filling the case management role. The differences may be explained by prescribing authority for Canadian pharmacists, however limited, and their ability to tweak therapy to the maximum benefit, according to the study authors. Here are the details.

U.S. Pharmacist Social Connect